Smith-Erichsen N, Aasen A O, Amundsen E
Adv Exp Med Biol. 1983;156 (Pt B):1049-54.
Functional kallikrein inhibition and prekallikrein levels have been studied during septic shock and septicemia in 13 patients using chromogenic peptide substrate assays. Eleven septic shock episodes were studied of which 5 were fatal. Marked reductions in functional kallikrein inhibition and prekallikrein values occurred during fatal septic shock. In patients who could be resuscitated from septic shock, functional kallikrein inhibition was in the normal range, but significantly lower than in patients with septicemia only. Also in these two groups of patients decreased prekallikrein values were found. During treatment a gradual increase in prekallikrein was observed in the survivors and functional kallikrein inhibition values remained in the normal range during the whole course. Our results indicate that the functional inhibition of plasma kallikrein plays a major role in determining the outcome of septic shock.
利用生色肽底物分析法,对13例脓毒性休克和败血症患者的功能性激肽释放酶抑制作用及前激肽释放酶水平进行了研究。研究了11次脓毒性休克发作,其中5例死亡。在致命性脓毒性休克期间,功能性激肽释放酶抑制作用和前激肽释放酶值显著降低。在可从脓毒性休克中复苏的患者中,功能性激肽释放酶抑制作用在正常范围内,但明显低于仅患败血症的患者。在这两组患者中也发现前激肽释放酶值降低。在治疗过程中,幸存者的前激肽释放酶逐渐升高,并且在整个病程中功能性激肽释放酶抑制值保持在正常范围内。我们的结果表明,血浆激肽释放酶的功能性抑制在决定脓毒性休克的结局中起主要作用。